Aktie A2QJS1 KAYA HOLDINGS, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Kaya Holdings, Inc.

Aktien

A2QJS1

US4865672095

KAYS

Verzögert OTC Markets
Andere Börsenplätze
 15:30:02 03.05.2024 		% 5 Tage % 1. Jan.
0,035 USD -7,89 % Intraday Chart für Kaya Holdings, Inc. -18,60 % -16,86 %
16.04. Kaya Holdings, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI
2023 Kaya Holdings, Inc. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Investor Ideas Potcasts: Interview with Kaya Holdings on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Pioneers and Innovators in Psilocybin Treatments and How Big Pharma Wants in on the Game
Kaya Holdings, Inc. Secures Site for the Sacred Mushroom(TM) Planned Psilocybin Treatment Center
Kaya Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kaya Holdings, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)
Kaya Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Kaya Holdings, Inc. Auditor Raises 'Going Concern' Doubt
Kaya : Acquisition/Asset Disposal - Form 8-K
KAYA HOLDINGS, INC. : Completion of Acquisition or Disposition of Assets (form 8-K)
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
KAYA HOLDINGS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
Kaya Holdings, Inc. Launches Fifth Dimension Therapeutics to Seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Kaya Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
KAYA HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
Kaya : to Seek Licenses for First Ever State Legal Psilocybin Manufacturing and Facilitation Service Centers in Oregon
Kaya : Cannabis Company Kaya Holdings, Inc’s Greek Joint Venture Receives Crucial Installation License for 50K Sq. Ft. Medical Cannabis Facility in Epidaurus, Greece - Form 8-K
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QJS1 Aktie
  4. Nachrichten Kaya Holdings, Inc.
  5. Andere Sprachen